Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Superficial venous ablation · Nevada | Superficial venous ablation · California | |
|---|---|---|
| Surgeons, 2024 | 19 | 224 |
| Medicare fee-for-service cases | 2,060 | 22,010 |
| Growth since 2019 (Medicare FFS) | −8.7%/yr | −1.1%/yr |
| Forecast cases (Medicare FFS) | 2,270 in 2030 | 24,700 in 2030 |
| Forecast growth | +1.7%/yr to 2030 | +2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 6.8 | 6.3 |
| Medicare Advantage share | 56% | 56% |
| Out of hospital | 99% (−1 pts since 2019) | 98% (−1 pts since 2019) |
| Cases per surgeon | 108 | 98 |
| Top 10 surgeons' share | 88% | 30% |
| Surgeons growing | 6 | 48 |
| New since the base year | 0 | 54 |
| Likely to stop billing it | 6 by 2026 | 40 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $422 | $251 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.